T60c
/ Cancer Hospital of Chinese Academy of Medical Sciences
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 13, 2023
A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients
(clinicaltrials.gov)
- P1/2 | N=62 | Not yet recruiting | Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Metastases • New P1/2 trial • Breast Cancer • Colorectal Cancer • Endometrial Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • Hormone Receptor Breast Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Prostate Cancer • Solid Tumor • Triple Negative Breast Cancer
1 to 1
Of
1
Go to page
1